nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—ESR1—migraine	0.832	1	CbGaD
Fluoxymesterone—PRLR—Ovarian Infertility Genes—PGR—migraine	0.00585	0.0984	CbGpPWpGaD
Fluoxymesterone—Polycythaemia—Topiramate—migraine	0.00566	0.0682	CcSEcCtD
Fluoxymesterone—PRLR—Nuclear signaling by ERBB4—PGR—migraine	0.00499	0.084	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—MEF2D—migraine	0.00372	0.0626	CbGpPWpGaD
Fluoxymesterone—Clotting—Topiramate—migraine	0.00346	0.0417	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Valproic Acid—migraine	0.0032	0.0386	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Amitriptyline—migraine	0.00299	0.036	CcSEcCtD
Fluoxymesterone—PRLR—Nuclear signaling by ERBB4—ESR1—migraine	0.00267	0.0448	CbGpPWpGaD
Fluoxymesterone—Libido decreased—Amitriptyline—migraine	0.00261	0.0315	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Valproic Acid—migraine	0.0026	0.0313	CcSEcCtD
Fluoxymesterone—Hirsutism—Gabapentin—migraine	0.00253	0.0305	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Amitriptyline—migraine	0.0024	0.029	CcSEcCtD
Fluoxymesterone—Coagulopathy—Valproic Acid—migraine	0.00228	0.0274	CcSEcCtD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—FOS—migraine	0.00227	0.0382	CbGpPWpGaD
Fluoxymesterone—Gynaecomastia—Verapamil—migraine	0.00224	0.0269	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Gabapentin—migraine	0.00216	0.026	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Propranolol—migraine	0.00204	0.0246	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Valproic Acid—migraine	0.00202	0.0243	CcSEcCtD
Fluoxymesterone—Coagulopathy—Gabapentin—migraine	0.00189	0.0227	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Topiramate—migraine	0.00181	0.0218	CcSEcCtD
Fluoxymesterone—PRLR—brain—migraine	0.00179	0.101	CbGeAlD
Fluoxymesterone—Dydrogesterone—PGR—migraine	0.00179	0.229	CrCbGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—PGR—migraine	0.00168	0.0283	CbGpPWpGaD
Fluoxymesterone—Amenorrhoea—Gabapentin—migraine	0.00167	0.0201	CcSEcCtD
Fluoxymesterone—Coagulopathy—Topiramate—migraine	0.00159	0.0191	CcSEcCtD
Fluoxymesterone—Alopecia—Amitriptyline—migraine	0.00148	0.0178	CcSEcCtD
Fluoxymesterone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—migraine	0.00141	0.0237	CbGpPWpGaD
Fluoxymesterone—Amenorrhoea—Topiramate—migraine	0.00141	0.0169	CcSEcCtD
Fluoxymesterone—NR3C1—Circadian Clock—MEF2D—migraine	0.00137	0.023	CbGpPWpGaD
Fluoxymesterone—Gynaecomastia—Gabapentin—migraine	0.00132	0.0158	CcSEcCtD
Fluoxymesterone—SHBG—neck—migraine	0.00126	0.0714	CbGeAlD
Fluoxymesterone—ESR1—blood vessel—migraine	0.00124	0.0703	CbGeAlD
Fluoxymesterone—AR—Nuclear Receptors—PGR—migraine	0.00124	0.0209	CbGpPWpGaD
Fluoxymesterone—Anxiety—Amitriptyline—migraine	0.00124	0.0149	CcSEcCtD
Fluoxymesterone—Libido decreased—Timolol—migraine	0.00124	0.0149	CcSEcCtD
Fluoxymesterone—Alopecia—Propranolol—migraine	0.00121	0.0145	CcSEcCtD
Fluoxymesterone—NR3C1—nerve—migraine	0.00117	0.0661	CbGeAlD
Fluoxymesterone—Libido decreased—Gabapentin—migraine	0.00115	0.0139	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Timolol—migraine	0.00114	0.0137	CcSEcCtD
Fluoxymesterone—Alopecia—Verapamil—migraine	0.00111	0.0134	CcSEcCtD
Fluoxymesterone—Megestrol acetate—PGR—migraine	0.00108	0.138	CrCbGaD
Fluoxymesterone—Paraesthesia—Amitriptyline—migraine	0.00107	0.0129	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Gabapentin—migraine	0.00106	0.0127	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—ATP1A3—migraine	0.00101	0.017	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—PGR—migraine	0.000982	0.0165	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Propranolol—migraine	0.00097	0.0117	CcSEcCtD
Fluoxymesterone—Libido decreased—Topiramate—migraine	0.000968	0.0117	CcSEcCtD
Fluoxymesterone—SHBG—brainstem—migraine	0.000966	0.0546	CbGeAlD
Fluoxymesterone—ESR1—Nuclear Receptors—PGR—migraine	0.000957	0.0161	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—PGR—migraine	0.000943	0.0159	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear signaling by ERBB4—PGR—migraine	0.000937	0.0158	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—ESR1—migraine	0.000898	0.0151	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Valproic Acid—migraine	0.000895	0.0108	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Verapamil—migraine	0.000892	0.0107	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Topiramate—migraine	0.00089	0.0107	CcSEcCtD
Fluoxymesterone—Haemorrhage—Valproic Acid—migraine	0.00089	0.0107	CcSEcCtD
Fluoxymesterone—ESR1—neck—migraine	0.00089	0.0503	CbGeAlD
Fluoxymesterone—Paraesthesia—Propranolol—migraine	0.000871	0.0105	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HTR3A—migraine	0.000857	0.0144	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Verapamil—migraine	0.000801	0.00965	CcSEcCtD
Fluoxymesterone—SHBG—cardiovascular system—migraine	0.000788	0.0445	CbGeAlD
Fluoxymesterone—Alopecia—Valproic Acid—migraine	0.000787	0.00947	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000765	0.0129	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—PGR—migraine	0.000756	0.0127	CbGpPWpGaD
Fluoxymesterone—Headache—Amitriptyline—migraine	0.000746	0.00899	CcSEcCtD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—PGR—migraine	0.000745	0.0125	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Gabapentin—migraine	0.000738	0.00889	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Propranolol—migraine	0.000715	0.0086	CcSEcCtD
Fluoxymesterone—Nausea—Amitriptyline—migraine	0.000708	0.00852	CcSEcCtD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—FOS—migraine	0.000704	0.0118	CbGpPWpGaD
Fluoxymesterone—Alopecia—Timolol—migraine	0.0007	0.00843	CcSEcCtD
Fluoxymesterone—Danazol—PGR—migraine	0.000698	0.0894	CrCbGaD
Fluoxymesterone—NR3C1—Adipogenesis—MEF2D—migraine	0.000688	0.0116	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—FOS—migraine	0.000688	0.0116	CbGpPWpGaD
Fluoxymesterone—ESR1—brainstem—migraine	0.00068	0.0384	CbGeAlD
Fluoxymesterone—Spironolactone—PGR—migraine	0.000669	0.0857	CrCbGaD
Fluoxymesterone—AR—Nuclear Receptors—ESR1—migraine	0.000663	0.0112	CbGpPWpGaD
Fluoxymesterone—Anxiety—Valproic Acid—migraine	0.000658	0.00792	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Verapamil—migraine	0.000657	0.00792	CcSEcCtD
Fluoxymesterone—NR3C1—neck—migraine	0.000657	0.0371	CbGeAlD
Fluoxymesterone—Alopecia—Gabapentin—migraine	0.000652	0.00785	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HTR3A—migraine	0.00065	0.0109	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Valproic Acid—migraine	0.000633	0.00762	CcSEcCtD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—PGR—migraine	0.000631	0.0106	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—PGR—migraine	0.000627	0.0803	CrCbGaD
Fluoxymesterone—Haemoglobin—Topiramate—migraine	0.000624	0.00752	CcSEcCtD
Fluoxymesterone—Norethindrone—PGR—migraine	0.000621	0.0796	CrCbGaD
Fluoxymesterone—Haemorrhage—Topiramate—migraine	0.000621	0.00748	CcSEcCtD
Fluoxymesterone—AR—FOXA1 transcription factor network—ESR1—migraine	0.00059	0.00992	CbGpPWpGaD
Fluoxymesterone—Anxiety—Timolol—migraine	0.000585	0.00705	CcSEcCtD
Fluoxymesterone—Nausea—Propranolol—migraine	0.000576	0.00694	CcSEcCtD
Fluoxymesterone—Betamethasone—PGR—migraine	0.000569	0.0729	CrCbGaD
Fluoxymesterone—Paraesthesia—Valproic Acid—migraine	0.000568	0.00684	CcSEcCtD
Fluoxymesterone—NR3C1—trigeminal ganglion—migraine	0.000567	0.032	CbGeAlD
Fluoxymesterone—AR—cardiovascular system—migraine	0.000566	0.032	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Timolol—migraine	0.000563	0.00678	CcSEcCtD
Fluoxymesterone—Headache—Verapamil—migraine	0.000559	0.00673	CcSEcCtD
Fluoxymesterone—ESR1—cardiovascular system—migraine	0.000555	0.0314	CbGeAlD
Fluoxymesterone—Alopecia—Topiramate—migraine	0.000549	0.00661	CcSEcCtD
Fluoxymesterone—Anxiety—Gabapentin—migraine	0.000545	0.00656	CcSEcCtD
Fluoxymesterone—AR—FOXA1 transcription factor network—FOS—migraine	0.000532	0.00894	CbGpPWpGaD
Fluoxymesterone—Nausea—Verapamil—migraine	0.00053	0.00638	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Gabapentin—migraine	0.000524	0.00631	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—ESR1—migraine	0.000524	0.00882	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RAMP1—migraine	0.000522	0.00878	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CALCRL—migraine	0.000522	0.00878	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Timolol—migraine	0.000506	0.00609	CcSEcCtD
Fluoxymesterone—NR3C1—Nuclear Receptors—ESR1—migraine	0.000503	0.00847	CbGpPWpGaD
Fluoxymesterone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—migraine	0.000503	0.00847	CbGpPWpGaD
Fluoxymesterone—NR3C1—brainstem—migraine	0.000502	0.0284	CbGeAlD
Fluoxymesterone—PRLR—Adipogenesis—TNF—migraine	0.000493	0.00829	CbGpPWpGaD
Fluoxymesterone—SHBG—central nervous system—migraine	0.000487	0.0275	CbGeAlD
Fluoxymesterone—SHBG—cerebellum—migraine	0.000476	0.0269	CbGeAlD
Fluoxymesterone—Paraesthesia—Gabapentin—migraine	0.000471	0.00567	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Valproic Acid—migraine	0.000466	0.00561	CcSEcCtD
Fluoxymesterone—Anxiety—Topiramate—migraine	0.000459	0.00552	CcSEcCtD
Fluoxymesterone—Danazol—ESR1—migraine	0.000441	0.0564	CrCbGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—FOS—migraine	0.000425	0.00715	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Timolol—migraine	0.000415	0.005	CcSEcCtD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—FOS—migraine	0.00041	0.00689	CbGpPWpGaD
Fluoxymesterone—NR3C1—cardiovascular system—migraine	0.00041	0.0231	CbGeAlD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HTR1A—migraine	0.000408	0.00686	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TAC1—migraine	0.000401	0.00675	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—ESR1—migraine	0.000398	0.00669	CbGpPWpGaD
Fluoxymesterone—Headache—Valproic Acid—migraine	0.000396	0.00477	CcSEcCtD
Fluoxymesterone—Paraesthesia—Topiramate—migraine	0.000396	0.00477	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—migraine	0.000396	0.0507	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000394	0.00662	CbGpPWpGaD
Fluoxymesterone—SHBG—brain—migraine	0.000387	0.0218	CbGeAlD
Fluoxymesterone—Hypersensitivity—Gabapentin—migraine	0.000386	0.00465	CcSEcCtD
Fluoxymesterone—AR—head—migraine	0.000383	0.0216	CbGeAlD
Fluoxymesterone—PRLR—Signaling Pathways—HTR1D—migraine	0.000379	0.00638	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—migraine	0.000378	0.00635	CbGpPWpGaD
Fluoxymesterone—ESR1—head—migraine	0.000376	0.0212	CbGeAlD
Fluoxymesterone—Nausea—Valproic Acid—migraine	0.000376	0.00452	CcSEcCtD
Fluoxymesterone—AR—nervous system—migraine	0.000363	0.0205	CbGeAlD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	0.000362	0.00609	CbGpPWpGaD
Fluoxymesterone—Progesterone—PGR—migraine	0.000362	0.0464	CrCbGaD
Fluoxymesterone—ESR1—nervous system—migraine	0.000356	0.0201	CbGeAlD
Fluoxymesterone—Headache—Timolol—migraine	0.000353	0.00425	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—HTR2B—migraine	0.000353	0.00593	CbGpPWpGaD
Fluoxymesterone—AR—central nervous system—migraine	0.00035	0.0197	CbGeAlD
Fluoxymesterone—ESR1—central nervous system—migraine	0.000343	0.0194	CbGeAlD
Fluoxymesterone—ESR1—cerebellum—migraine	0.000335	0.019	CbGeAlD
Fluoxymesterone—Nausea—Timolol—migraine	0.000334	0.00403	CcSEcCtD
Fluoxymesterone—Dexamethasone—PGR—migraine	0.000331	0.0424	CrCbGaD
Fluoxymesterone—Headache—Gabapentin—migraine	0.000329	0.00396	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	0.000326	0.00549	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Topiramate—migraine	0.000325	0.00391	CcSEcCtD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—FOS—migraine	0.000324	0.00545	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PGR—migraine	0.000316	0.00531	CbGpPWpGaD
Fluoxymesterone—Nausea—Gabapentin—migraine	0.000311	0.00375	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—LRP1—migraine	0.00031	0.00522	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HTR1A—migraine	0.000309	0.0052	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—ESR1—migraine	0.000309	0.00519	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000305	0.00513	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TAC1—migraine	0.000305	0.00512	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000299	0.00502	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—FOS—migraine	0.000289	0.00486	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—BDNF—migraine	0.000286	0.00481	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—FOS—migraine	0.000283	0.00475	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—FOS—migraine	0.000278	0.00468	CbGpPWpGaD
Fluoxymesterone—AR—brain—migraine	0.000278	0.0157	CbGeAlD
Fluoxymesterone—NR3C1—head—migraine	0.000277	0.0157	CbGeAlD
Fluoxymesterone—Headache—Topiramate—migraine	0.000276	0.00333	CcSEcCtD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	0.000275	0.00462	CbGpPWpGaD
Fluoxymesterone—ESR1—brain—migraine	0.000272	0.0154	CbGeAlD
Fluoxymesterone—NR3C1—nervous system—migraine	0.000263	0.0149	CbGeAlD
Fluoxymesterone—Nausea—Topiramate—migraine	0.000262	0.00316	CcSEcCtD
Fluoxymesterone—NR3C1—central nervous system—migraine	0.000253	0.0143	CbGeAlD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	0.000251	0.00423	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	0.000248	0.00416	CbGpPWpGaD
Fluoxymesterone—NR3C1—cerebellum—migraine	0.000247	0.014	CbGeAlD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—FOS—migraine	0.000245	0.00412	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000243	0.00409	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HTR2A—migraine	0.000241	0.00406	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH4—migraine	0.000238	0.00401	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000235	0.00395	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR1B—migraine	0.00023	0.00386	CbGpPWpGaD
Fluoxymesterone—Progesterone—ESR1—migraine	0.000229	0.0293	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR1A—migraine	0.000221	0.00372	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ESR1—migraine	0.00022	0.0037	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PGR—migraine	0.000218	0.00366	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NPS—migraine	0.000218	0.00366	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TAC1—migraine	0.000218	0.00366	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—BDNF—migraine	0.000217	0.00365	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR2C—migraine	0.000214	0.00359	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—migraine	0.000213	0.00357	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EDNRA—migraine	0.000208	0.00349	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH3—migraine	0.000202	0.00341	CbGpPWpGaD
Fluoxymesterone—NR3C1—brain—migraine	0.000201	0.0114	CbGeAlD
Fluoxymesterone—PRLR—Signaling Pathways—CALCA—migraine	0.0002	0.00336	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000187	0.00315	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR7—migraine	0.000187	0.00315	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH4—migraine	0.000185	0.00312	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HTR2A—migraine	0.000183	0.00308	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000182	0.00307	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PGR—migraine	0.00017	0.00285	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FOS—migraine	0.000162	0.00273	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFBR2—migraine	0.000161	0.00271	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH3—migraine	0.000158	0.00265	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH4—migraine	0.000143	0.0024	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH4—migraine	0.000141	0.00237	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR2A—migraine	0.000131	0.0022	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PGR—migraine	0.000131	0.0022	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PGR—migraine	0.000129	0.00216	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH3—migraine	0.000121	0.00204	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH3—migraine	0.00012	0.00201	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ESR1—migraine	0.000116	0.00196	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—migraine	0.000104	0.00175	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAMP1—migraine	9.8e-05	0.00165	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CALCRL—migraine	9.8e-05	0.00165	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—migraine	9.12e-05	0.00153	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR1—migraine	9.06e-05	0.00152	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH4—migraine	8.93e-05	0.0015	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—migraine	8.83e-05	0.00149	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PGR—migraine	8.17e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—migraine	7.88e-05	0.00133	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH3—migraine	7.59e-05	0.00128	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR1D—migraine	7.12e-05	0.0012	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH4—migraine	6.88e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—migraine	6.87e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—migraine	6.8e-05	0.00114	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH4—migraine	6.77e-05	0.00114	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR2B—migraine	6.62e-05	0.00111	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PGR—migraine	6.29e-05	0.00106	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PGR—migraine	6.19e-05	0.00104	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH3—migraine	5.85e-05	0.000984	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LRP1—migraine	5.83e-05	0.00098	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH3—migraine	5.76e-05	0.000969	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH4—migraine	4.47e-05	0.000752	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—migraine	4.36e-05	0.000733	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR1B—migraine	4.31e-05	0.000726	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR1A—migraine	4.15e-05	0.000699	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NPS—migraine	4.09e-05	0.000688	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PGR—migraine	4.09e-05	0.000688	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TAC1—migraine	4.09e-05	0.000688	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR2C—migraine	4.01e-05	0.000675	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDNRA—migraine	3.9e-05	0.000656	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH3—migraine	3.8e-05	0.00064	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CALCA—migraine	3.76e-05	0.000632	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR7—migraine	3.51e-05	0.000591	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—migraine	3.31e-05	0.000556	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFBR2—migraine	3.03e-05	0.000509	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR2A—migraine	2.46e-05	0.000414	CbGpPWpGaD
